Doctors making house calls? It sounds so …19th century, conjuring up images of a tweedy medical practitioner arriving on someone’s doorstep by horse and buggy with a medical bag and a stethoscope.
Call it the point-of-care revolution: The accelerating shift of patients from overcrowded doctors’ offices to accessible, clinically engaged pharmacists and retail clinicians for front-line health-and-wellness services.
Miraculins on Tuesday announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone, Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario.
Flu incidence is not ony predominant but still on the rise across Oklahoma, Arkansas and Texas.
Actavis on Monday agreed to acquire Auden Mckenzie Holdings for approximately $465.8 million in cash, plus a two-year royalty on a percentage of gross profits of one of Auden Mckenzie's products.
Symplmed Pharmaceuticals announced that the Food and Drug Administration approved Prestalia (perindopril arginine and amlodipine) tablets to treat hypertension.
Rep. Jason Chaffetz, R-Utah, last week introduced a bill that would extend to new combination drugs containing molecules already approved by the Food and Drug Administration the same five-year market exclusivity as a drug product containing an entirely new set of active ingredients.
HIV patients using a mobile app are 2.9 times more likely to be adherent.
Health and Human Services Secretary Sylvia Burwell announced goals and a timeline to move the Medicare program toward paying providers based on the quality of care they give patients.
Teva Pharmaceutical Industries announced that the Food and Drug Administration approved the company’s first generic Nexium delayed-release tablets in the United States.